French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and Medidata, a Dassault Systèmes (Euronext Paris:DSY) brand, on Thursday announced an expansion of their more than 10-year collaboration to enhance clinical research.

The partnership will leverage Medidata Experiences across patient, data, and study workflows to streamline operations, improve data quality, and advance patient care.

The platform-based solutions integrate AI into clinical trial processes, reducing fragmentation, lowering costs, and accelerating timelines.

Sanofi will utilise Medidata's expertise in decentralised clinical trials as part of the agreement. Medidata will provide strategic consulting and end-to-end operational support, enabling Sanofi to optimise research processes and enhance the precision and impact of therapy development.